243 related articles for article (PubMed ID: 11039905)
1. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
2. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic transformation by the FOX protein Qin requires DNA binding.
Ma Y; Geerdes DW; Vogt PK
Oncogene; 2000 Oct; 19(42):4815-21. PubMed ID: 11039897
[TBL] [Abstract][Full Text] [Related]
4. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
5. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
[TBL] [Abstract][Full Text] [Related]
6. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
7. The oncogenicity of jun.
Vogt PK; Bos TJ; Mitsunobu F; Nishimura T; Monteclaro FS; Su HY
Princess Takamatsu Symp; 1989; 20():127-34. PubMed ID: 2562177
[TBL] [Abstract][Full Text] [Related]
8. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
9. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
10. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
11. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
[TBL] [Abstract][Full Text] [Related]
12. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
Kilbey A; Black EJ; Unlu M; Gillespie DA
Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
[TBL] [Abstract][Full Text] [Related]
13. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
[TBL] [Abstract][Full Text] [Related]
14. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
15. Jun, the oncoprotein.
Vogt PK
Oncogene; 2001 Apr; 20(19):2365-77. PubMed ID: 11402333
[TBL] [Abstract][Full Text] [Related]
16. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
17. The constitutive activation of the CEF-4/9E3 chemokine gene depends on C/EBPbeta in v-src transformed chicken embryo fibroblasts.
Gagliardi M; Maynard S; Bojovic B; Bédard PA
Oncogene; 2001 Apr; 20(18):2301-13. PubMed ID: 11402325
[TBL] [Abstract][Full Text] [Related]
18. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.
Oehler T; Pintzas A; Stumm S; Darling A; Gillespie D; Angel P
Oncogene; 1993 May; 8(5):1141-7. PubMed ID: 8479739
[TBL] [Abstract][Full Text] [Related]
19. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
Schuur ER; Parker EJ; Vogt PK
Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of genes upregulated in cells transformed by v-Jun.
Fu SL; Waha A; Vogt PK
Oncogene; 2000 Jul; 19(31):3537-45. PubMed ID: 10918612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
